CPC A61K 31/155 (2013.01) [A61K 9/0021 (2013.01); A61K 9/0024 (2013.01); A61K 9/0048 (2013.01); A61K 9/1641 (2013.01); A61K 9/1647 (2013.01); A61K 9/1658 (2013.01); A61K 31/337 (2013.01); A61K 31/37 (2013.01); A61K 31/496 (2013.01); A61K 31/573 (2013.01); A61K 31/7036 (2013.01); A61K 31/727 (2013.01); A61K 41/0028 (2013.01); A61K 47/34 (2013.01); A61L 27/50 (2013.01); A61L 27/54 (2013.01); A61M 37/0015 (2013.01); A61L 2400/06 (2013.01); A61M 5/3015 (2013.01); A61M 37/0069 (2013.01); A61M 37/0076 (2013.01); A61M 2037/0023 (2013.01); A61M 2205/3606 (2013.01); A61M 2205/3653 (2013.01); C12Y 304/21068 (2013.01); C12Y 304/24069 (2013.01)] | 24 Claims |
1. A method of forming an implant in tissue, the method comprising:
providing a polymer solution having an effective amount of polymer dissolved in a biocompatible, water-soluble organic solvent;
injecting a plurality of droplets of the polymer solution in the tissue;
fusing the injected droplets together;
dissipating the biocompatible, water-soluble organic solvent in the tissue; and
precipitating the polymer from the injected polymer solution so as to form the implant.
|